Compare TECH & GMED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TECH | GMED |
|---|---|---|
| Founded | 1976 | 2003 |
| Country | | |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.2B | 11.7B |
| IPO Year | N/A | N/A |
| Metric | TECH | GMED |
|---|---|---|
| Price | $58.52 | $89.22 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 13 | 15 |
| Target Price | $72.67 | ★ $97.15 |
| AVG Volume (30 Days) | ★ 2.6M | 1.1M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 0.55% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $2.49 | $17.97 |
| Revenue Next Year | $6.40 | $8.61 |
| P/E Ratio | $112.66 | ★ $28.90 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $46.01 | $51.79 |
| 52 Week High | $72.16 | $101.40 |
| Indicator | TECH | GMED |
|---|---|---|
| Relative Strength Index (RSI) | 35.31 | 49.00 |
| Support Level | $58.04 | $86.07 |
| Resistance Level | $69.92 | $89.64 |
| Average True Range (ATR) | 2.89 | 2.59 |
| MACD | -1.09 | -0.27 |
| Stochastic Oscillator | 4.34 | 39.76 |
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.
Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.